Diplomat Specialty Pharmacy, the nation’s largest independent specialty pharmacy in the nation, announced today it has received limited distribution rights from Regeneron for its new drug EYLEA™ (aflibercept) Injection. On November 18, 2011, EYLEA (aflibercept) Injection was approved by the Food and Drug Administration and is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD). Macular degeneration is diagnosed as either dry (non-vascular) or wet (vascular) and is a leading cause of blindness in older adults. The wet form usually leads to more serious vision loss.

(PRWeb January 09, 2012)

Read the full story at

“As we begin 2012, we are making raising awareness about glaucoma a priority’” stated Connecticut Ophthalmologist Leslie Doctor, M.D. of Doctor & Associates with offices located in Westport, Norwalk and Wilton.

(PRWeb January 07, 2012)

Read the full story at

“At Eyecare Medical Group in Portland, Maine, January represents the time we pay particular attention to getting the word out reminding patients to take advantage of the advances in the diagnosis and treatment of glaucoma as this sight stealing eye disease is a leading cause of preventable blindness,” commented Clement Berry, Chief Executive Officer of Eyecare Medical Group.

(PRWeb January 05, 2012)

Read the full story at

Residents of Clearwater and Tampa Bay Are Invited to Sign Up for the Eye Shop Grand Opening Event

(PRWeb December 27, 2011)

Read the full story at

Residents of Clearwater and Tampa Bay Are Invited to Sign Up for the Eye Shop Grand Opening Event

(PRWeb December 27, 2011)

Read the full story at